These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4088201)

  • 1. [Recent advances in artificial blood].
    Motoki R; Usuba A; Inoue H; Miura J
    Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1031-4. PubMed ID: 4088201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination.
    Ravis WR; Hoke JF; Parsons DL
    Drug Metab Rev; 1991; 23(3-4):375-411. PubMed ID: 1935577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Red Cross lecture. Current concepts of oxygen-transporting blood substitutes.
    Bolin RB
    Can J Surg; 1982 Jul; 25(4):422-4. PubMed ID: 7046893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
    Suyama T; Yokoyama K; Naito R
    Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment of cerebral vasospasm with Fluosol-DA 20%: protective effect on cerebral ischemia and change of cerebral blood flow (CBF).
    Handa H; Nagasawa S; Yonekawa Y; Naruo Y; Oda Y
    Prog Clin Biol Res; 1983; 122():299-306. PubMed ID: 6878374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R; Peerless SJ; Hunter IG
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study of cerebral protective effect on cerebral ischemia of various antioxidants and other agents. With special reference to the combined treatment of mannitol, vitamin E, dexamethasone and perfluorochemicals].
    Fujimoto S; Mizoi K; Oba M; Suzuki J
    No Shinkei Geka; 1984 Feb; 12(2):171-80. PubMed ID: 6325977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluosol-DA in extracorporeal circulation - an experimental study (author's transl)].
    Ozono H; Taira A; Toyohira H; Higashi T; Yamashita M; Shimokawa S; Umebayashi Y; Saigenji H; Hamada Y; Arikawa K; Akita H
    Kyobu Geka; 1981 Oct; 34(10):776-80. PubMed ID: 7311221
    [No Abstract]   [Full Text] [Related]  

  • 9. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA; Holden SA; Jacobs JL
    Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and clinical application of perfluorochemical artificial blood.
    Ohyanagi H; Saitoh Y
    Int J Artif Organs; 1986 Sep; 9(5):363-8. PubMed ID: 3781670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a hemoglobin substitute in the anemic Jehovah's Witness patient.
    Marelli TR
    Crit Care Nurse; 1994 Feb; 14(1):31-8. PubMed ID: 8194324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange.
    Hiraga S; Klubes P; Owens ES; Cysyk RL; Blasberg RG
    Cancer Res; 1987 Jun; 47(12):3296-302. PubMed ID: 3581070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perflubron emulsion improves hepatic microvascular integrity and mitochondrial redox state after hemorrhagic shock.
    Paxian M; Keller SA; Huynh TT; Clemens MG
    Shock; 2003 Nov; 20(5):449-57. PubMed ID: 14560110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the protective effects on the ischemic myocardium of coronary perfusion with perfluorochemicals (fluosol-DA)--a comparison with cold blood cardioplegia].
    Ishimaru S; Hirayama T; Uchino T; Hakoshima A; Hino H; Yamada M; Koike S; Furukawa K; Takahashi M; Yoshihama I
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Jan; 34(1):62-8. PubMed ID: 3711703
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
    No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined use of mannitol and perfluorochemicals in experimental cerebral ischemia].
    Mizoi K; Yoshimoto T; Suzuki J
    No To Shinkei; 1983 Jul; 35(7):669-76. PubMed ID: 6414497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of injectable oxygen carriers.
    Zuck TF; Riess JG
    Crit Rev Clin Lab Sci; 1994; 31(4):295-324. PubMed ID: 7888075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Artificial oxygen carriers. Alternatives to homologous blood transfusion?].
    Habler O; Kleen M; Messmer K
    Zentralbl Chir; 1999; 124(4):260-70. PubMed ID: 10355079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contrast material with oxygenated Fluosol-DA, 20 for the protection against complications of catheter cerebral angiography].
    Oda Y; Okumura T; Morimoto M; Murata T; Kamimura Y; Uchida Y; Mori K
    No Shinkei Geka; 1984 Nov; 12(12):1369-77. PubMed ID: 6521827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with Fluosol-DA.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
    Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.